Literature DB >> 15466079

Life-threatening human metapneumovirus pneumonia requiring extracorporeal membrane oxygenation in a preterm infant.

Rolando Ulloa-Gutierrez1, Peter Skippen, Anne Synnes, Michael Seear, Nathalie Bastien, Yan Li, John C Forbes.   

Abstract

We present the first report in the literature of a child with human metapneumovirus pneumonia who required extracorporeal membrane oxygenation for survival. This was a 3-month-old premature boy from British Columbia, Canada, who developed severe respiratory failure, experienced failure of high-frequency oscillatory mechanical ventilation, and required extracorporeal membrane oxygenation support for 10 days. This case illustrates the importance of including this newly discovered pathogen among the causes of childhood pneumonia.

Entities:  

Mesh:

Year:  2004        PMID: 15466079     DOI: 10.1542/peds.2004-0345

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Human metapneumovirus infections in hospitalised infants in Spain.

Authors:  M L García-García; C Calvo; F Martín; P Pérez-Breña; B Acosta; I Casas
Journal:  Arch Dis Child       Date:  2006-01-06       Impact factor: 3.791

2.  Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.

Authors:  Nancy D Ulbrandt; Hong Ji; Nita K Patel; Jeffrey M Riggs; Yambasu A Brewah; Shannon Ready; Nanci E Donacki; Karyn Folliot; Arnita S Barnes; Kannaki Senthil; Susan Wilson; Mingzhong Chen; Lori Clarke; Mia MacPhail; Jia Li; Robert M Woods; Kathy Coelingh; Jennifer L Reed; Michael P McCarthy; David S Pfarr; Albert D M E Osterhaus; Ron A M Fouchier; Peter A Kiener; JoAnn A Suzich
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Human metapneumovirus infection as an emerging pathogen causing acute respiratory distress syndrome.

Authors:  Luregn Jan Schlapbach; Philipp Agyeman; Damian Hutter; Christoph Aebi; Bendicht Peter Wagner; Thomas Riedel
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections.

Authors:  Anja Wilkesmann; Oliver Schildgen; Anna Maria Eis-Hübinger; Tilman Geikowski; Thomas Glatzel; Michael J Lentze; Udo Bode; Arne Simon
Journal:  Eur J Pediatr       Date:  2006-03-23       Impact factor: 3.183

Review 5.  Epidemiology of human metapneumovirus.

Authors:  Jeffrey S Kahn
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Predictors of outcome for children requiring respiratory extra-corporeal life support: implications for inclusion and exclusion criteria.

Authors:  Nazima Pathan; Deborah A Ridout; Elizabeth Smith; Allan P Goldman; Katherine L Brown
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

7.  Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation.

Authors:  Aaron Derdowski; Timothy R Peters; Nancy Glover; Ray Qian; Thomas J Utley; Atuhani Burnett; John V Williams; Paul Spearman; James E Crowe
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

8.  A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Authors:  John V Williams; Zhifeng Chen; Gabriella Cseke; David W Wright; Christopher J Keefer; Sharon J Tollefson; Ann Hessell; Amy Podsiad; Bryan E Shepherd; Pietro Paolo Sanna; Dennis R Burton; James E Crowe; R Anthony Williamson
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

9.  Respiratory failure secondary to human metapneumovirus requiring extracorporeal membrane oxygenation in a 32-month-old child.

Authors:  Abha Gupta; Melania Bembea; Anna Brown; Courtney Robertson; Lewis Romer; Ronald D Cohn
Journal:  Case Rep Pediatr       Date:  2012-05-22

10.  Human metapneumovirus infections in children.

Authors:  Terho Heikkinen; Riikka Osterback; Ville Peltola; Tuomas Jartti; Raija Vainionpää
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.